European Parliament urges the Commission to immediately ask the European Food Safety Authority (EFSA) to re-evaluate the use of acetaldehyde

Biohit Oyj Press Release May 6, 2015 at 9:30 a.m. local time (EEST)

The motion of the European Parliament´s committee on Environment, Public Health and Food Safety (ENVI) has been accepted containing the key elements regarding acetaldehyde.

In the European Parliament Motion for a resolution on Alcohol Strategy (2015/2543(RSP)), it is concluded that food is to be deemed unsafe if it is considered to be injurious to health (Regulation (EC) No 178/2002 of 28 January 2002).

European Parliament urges the Commission to immediately ask the European Food Safety Authority (EFSA) to re-evaluate the use of acetaldehyde as a flavouring substance in alcoholic and non-alcoholic beverages.

European Parliament urges the Commission to produce immediately the report required in Regulation (EU) No 1169/2011 by December 2014, evaluating whether alcoholic beverages should in future be covered by the requirement to provide information on ingredients and nutritional content; considers that consumers should be informed about ingredients and nutritional content.

MEP Sirpa Pietikäinen: ‘I am very happy that awareness concerning carcinogenic acetaldehyde is taken seriously by the European Parliament. Informed consumers are empowered consumers.’

CEO Semi Korpela, Biohit Oyj: ‘Acetaldehyde is the most common carcinogen in the world.’

 

Additional information: 
CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com


Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com

About Us

Biohit in briefBiohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com

Subscribe